Seizure Decision Tool Android

Seizure Decision Tool

By: Atif Elnil App
Bedside decisions for new-onset seizures, seizure emergencies, scans & driving

Overview

Features & Capabilities

Seizure Decision Tool is a fast, evidence-based decision-support reference for clinicians managing patients with seizures — in the emergency department, on the acute medical take, on-call, in neurology, and in general practice.

When someone has a seizure, the decisions come quickly: is this provoked or unprovoked? Do they need a scan today? Should an anti-epileptic drug be started? Is this status epilepticus — and if so, what goes in, and when? This tool walks you through each of those decisions clearly, so you can act with confidence at the bedside.

WHAT'S INSIDE

- First Seizure — Initial Assessment
Provoked vs unprovoked classification, bloods, when to image, EEG, and the neurology referral timelines.

- Provoked vs Unprovoked Seizure
Acute symptomatic causes to identify and treat, recurrence risk, and the evidence-based AED decision after a first seizure.

- Status Epilepticus — Time-Critical Protocol
A minute-by-minute pathway from stabilisation through first-line benzodiazepines, second-line agents, and refractory management — built around treating at 5 minutes, not 30.

- When to Scan — CT, MRI and EEG
Same-day CT indications, the elective epilepsy-protocol MRI, and what an EEG does and does not tell you.

- First Fit — Elderly vs Young Adult
Different causes, different risks, different thresholds across age groups.

- PRES — Posterior Reversible Encephalopathy Syndrome
Recognition, the MRI pattern, and management.

- DVLA Driving Rules
Group 1 and Group 2 licence restrictions for first seizures, established epilepsy, nocturnal seizures, and medication changes — with a documentation checklist.

- References & Citations
Every recommendation is linked to its source — NICE NG217 (2022), SIGN 70, DVLA (2022), MHRA, and landmark trials including ESETT, ConSEPT, Magpie, and the ILAE definitions.

DESIGNED FOR THE WAY YOU WORK
- Works fully offline — no connection needed at the bedside.
- Clean, fast, distraction-free interface.
- Adjustable text size.
- No accounts, no tracking, no ads.

FREE TO TRY
The First Seizure assessment and the Provoked vs Unprovoked pathway are free to explore. A single one-time in-app purchase (£9.99) unlocks the full tool — Status Epilepticus, When to Scan, Elderly, PRES, DVLA guidance, and the complete References library. One-time purchase, no subscription.

IMPORTANT — FOR HEALTHCARE PROFESSIONALS
This app is an educational and training decision-support tool intended for qualified healthcare professionals. It does not replace current national or local guidelines, formularies, or your own clinical judgement. Always confirm doses against the BNF and your local protocols, and seek senior review for complex cases. It is not intended for use by patients to self-diagnose or self-manage.

Developed by Dr Atif Elnil (MBBS, MRCP), Neurology and Stroke Fellow.

User Growth & Download Statistics

App
By:
Atif Elnil
Downloads:
53
Version:
1.2 Last updated: 2026-07-29
Version code:
9
Creation date:
2026-06-25
Publisher country:
GB GB
Permissions:
  • android.permission.INTERNET Low risk
  • com.android.vending.BILLING Low risk
  • android.permission.ACCESS_NETWORK_STATE Safe
  • com.android.vending.CHECK_LICENSE Safe
  • com.atifelnil.seizuredecisiontool.DYNAMIC_RECEIVER_NOT_EXPORTED_PERMISSION
Size:
22.02MB
Email:
At*****@gmail.com
URLs:
Website ,Privacy policy
Full description:
See detailed description
Source:
Google Play Store
Data ingested on:
2026-08-04
Compare stats and ranking:

Contact the developer

Chrome-Stats does not own this Android app. Please use these information below to contact the Android app developer.
Developed by:
Atif Elnil
Google Play Store
https://play.google.com/store/apps/details?id=com.atifelnil.seizuredecisiontool
Email:
At*****@gmail.com
Website:
https://atif-elnil-android-privacy.netlify.app/

Best Seizure Decision Tool Alternatives

Here are some Android apps that are similar to Seizure Decision Tool: